Skip to main content
Top
Published in: Journal of Ovarian Research 1/2013

Open Access 01-12-2013 | Research

Clinical governance network for clinical audit to improve quality in epithelial ovarian cancer management

Authors: Vincenzo Dario Mandato, Martino Abrate, Pierandrea De Iaco, Debora Pirillo, Gino Ciarlini, Maurizio Leoni, Giuseppe Comerci, Alessandro Ventura, Bruno Lenzi, Andrea Amadori, Federica Rosati, Ruby Martinello, Rossana De Palma, Chiara Ventura, Laura Maria Beatrice Belotti, Debora Formisano, Giovanni Battista La Sala, Gynecological Oncology Network of Emilia Romagna Region

Published in: Journal of Ovarian Research | Issue 1/2013

Login to get access

Abstract

Background

Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer. Several hospitals throughout the region provide primary treatment for these patients and it is well know that treatment quality is correlated to the hospital that delivers. The aim of this study was to investigate the management and treatment of EOC in a Region of the North Italy (Emilia-Romagna, Italy).

Methods

A multidisciplinary group made up of 11 physicians and 3 biostatisticians was formed in 2009 to perform clinical audits in order to identify quality indicators and to develop Region-wide workup in accordance with the principles of evidence-based medicine (EBM). The rationale was that, by setting up an oncogynecology network so as to achieve the best clinical practice, critical points would decrease or even be eliminated. Analysis of cases was based on the review of the medical records.

Results

614 EOC patients treated between 2007 and 2008 were identified. We found only 2 high-volume hospitals (≥ 21 patients/year), 3 medium-volume hospitals (11–20 operated patients/year), and 7 low-volume hospitals (≤ 10 operated patients /year). Only 222 patients (76.3%) had a histological diagnosis, FIGO surgical staging was reported only in 206 patients (70.9%) but not all standard surgical procedures were always performed, residual disease were not reported in all patients. No standard number of neoadjuvant chemotherapy cycles was observed.

Conclusions

The differences in terms of treatments provided led the multidisciplinary group to identify reference centers, to promote centralization, to ensure uniform and adequate treatment to patients treated in regional centers and to promote a new audit involving all regional hospitals to a complete review of the all the EOC patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127: 2893. 10.1002/ijc.25516PubMedCrossRef Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127: 2893. 10.1002/ijc.25516PubMedCrossRef
2.
go back to reference Bray F, Loos AH, Tognazzo S, La VC: Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries. Int J Cancer 2005, 113: 977. 10.1002/ijc.20649PubMedCrossRef Bray F, Loos AH, Tognazzo S, La VC: Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries. Int J Cancer 2005, 113: 977. 10.1002/ijc.20649PubMedCrossRef
3.
go back to reference Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010, 46: 765. 10.1016/j.ejca.2009.12.014PubMedCrossRef Ferlay J, Parkin DM, Steliarova-Foucher E: Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010, 46: 765. 10.1016/j.ejca.2009.12.014PubMedCrossRef
4.
go back to reference Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB: Cancer incidence in five continents. Lyon: IARC Scientific Publications; 2002. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB: Cancer incidence in five continents. Lyon: IARC Scientific Publications; 2002.
5.
go back to reference Heintz APM, Odincino F, Maisonneuve P: Carcinoma of the ovary. J Epidemiol Biostat 2001, 6: 107.PubMed Heintz APM, Odincino F, Maisonneuve P: Carcinoma of the ovary. J Epidemiol Biostat 2001, 6: 107.PubMed
6.
go back to reference Sant M, Aareleid T, Berrino F: Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol 2003, 14: 100.CrossRef Sant M, Aareleid T, Berrino F: Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol 2003, 14: 100.CrossRef
7.
go back to reference Bristow RE, Palis BE, Chi DS, Cliby WA: The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol 2010, 118: 262. 10.1016/j.ygyno.2010.05.025PubMedCrossRef Bristow RE, Palis BE, Chi DS, Cliby WA: The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol 2010, 118: 262. 10.1016/j.ygyno.2010.05.025PubMedCrossRef
8.
go back to reference Vernooij F, Heintz AP, Coebergh JW, Massuger LF, Witteveen PO, van der Graaf Y: Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands. Gynecol Oncol 2009, 112: 455. 10.1016/j.ygyno.2008.11.011PubMedCrossRef Vernooij F, Heintz AP, Coebergh JW, Massuger LF, Witteveen PO, van der Graaf Y: Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands. Gynecol Oncol 2009, 112: 455. 10.1016/j.ygyno.2008.11.011PubMedCrossRef
9.
go back to reference Verleye L, Vergote I, van der Zee AGJ: Patterns of care in surgery for ovarian cancer in Europe. EJSO 2010, 36: 108.CrossRef Verleye L, Vergote I, van der Zee AGJ: Patterns of care in surgery for ovarian cancer in Europe. EJSO 2010, 36: 108.CrossRef
10.
go back to reference Mercado C, Zingmond D, Karlan BY: Quality of care in advanced ovarian cancer: the importance of provider specialty. Gynecol Oncol 2010, 117: 18. 10.1016/j.ygyno.2009.12.033PubMedCrossRef Mercado C, Zingmond D, Karlan BY: Quality of care in advanced ovarian cancer: the importance of provider specialty. Gynecol Oncol 2010, 117: 18. 10.1016/j.ygyno.2009.12.033PubMedCrossRef
11.
go back to reference Jemal A, Siegel R, Ward E: Cancer statistics, 2008. CA Cancer J Clin 2008, 58: 71. 10.3322/CA.2007.0010PubMedCrossRef Jemal A, Siegel R, Ward E: Cancer statistics, 2008. CA Cancer J Clin 2008, 58: 71. 10.3322/CA.2007.0010PubMedCrossRef
12.
go back to reference du Bois A, Rochon J, Pfisterer J, Hoskins WJ: Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review. Gynecol Oncol 2009, 112: 422. 10.1016/j.ygyno.2008.09.036PubMedCrossRef du Bois A, Rochon J, Pfisterer J, Hoskins WJ: Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review. Gynecol Oncol 2009, 112: 422. 10.1016/j.ygyno.2008.09.036PubMedCrossRef
13.
go back to reference Bristow RE, Eisenhauer EL, Santillan A, Chi DS: Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction. Gynecol Oncol 2007, 104: 480. 10.1016/j.ygyno.2006.11.002PubMedCrossRef Bristow RE, Eisenhauer EL, Santillan A, Chi DS: Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction. Gynecol Oncol 2007, 104: 480. 10.1016/j.ygyno.2006.11.002PubMedCrossRef
14.
go back to reference Trimbos JB, Vergote I, Bolis G: Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer—Adjuvant Chemotherapy in Ovarian Neoplasm Trial. J Natl Cancer Inst 2003, 95: 113. 10.1093/jnci/95.2.113PubMedCrossRef Trimbos JB, Vergote I, Bolis G: Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer—Adjuvant Chemotherapy in Ovarian Neoplasm Trial. J Natl Cancer Inst 2003, 95: 113. 10.1093/jnci/95.2.113PubMedCrossRef
15.
go back to reference Timmers PJ, Zwinderman AH, Coens C, Vergote I, Trimbos JB: Understanding the problem of inadequately staging early ovarian cancer. Eur J Cancer 2010, 46: 880. 10.1016/j.ejca.2009.12.012PubMedCrossRef Timmers PJ, Zwinderman AH, Coens C, Vergote I, Trimbos JB: Understanding the problem of inadequately staging early ovarian cancer. Eur J Cancer 2010, 46: 880. 10.1016/j.ejca.2009.12.012PubMedCrossRef
16.
go back to reference Chan JK, Munro EG, Cheung MK: Association of lymphadenectomy and survival in stage 1 ovarian cancer patients. Obstet Gynecol 2007, 109: 12. 10.1097/01.AOG.0000249610.95885.efPubMedCrossRef Chan JK, Munro EG, Cheung MK: Association of lymphadenectomy and survival in stage 1 ovarian cancer patients. Obstet Gynecol 2007, 109: 12. 10.1097/01.AOG.0000249610.95885.efPubMedCrossRef
17.
go back to reference Verley L, Ottevanger PB, van der Graaf W, Reed NS, Vergote I: Gynaecological Cancer Group (GCG) of the European Organisation for Research and Treatment of Cancer (EORTC), EORTC-GCG process quality indicators for ovarian cancer surgery. Eur J Cancer 2009, 45: 517. 10.1016/j.ejca.2008.09.031CrossRef Verley L, Ottevanger PB, van der Graaf W, Reed NS, Vergote I: Gynaecological Cancer Group (GCG) of the European Organisation for Research and Treatment of Cancer (EORTC), EORTC-GCG process quality indicators for ovarian cancer surgery. Eur J Cancer 2009, 45: 517. 10.1016/j.ejca.2008.09.031CrossRef
18.
go back to reference Chi DS, Eisenhauer EL, Lang J: What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 2006, 103: 559. 10.1016/j.ygyno.2006.03.051PubMedCrossRef Chi DS, Eisenhauer EL, Lang J: What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol 2006, 103: 559. 10.1016/j.ygyno.2006.03.051PubMedCrossRef
19.
go back to reference du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J: Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer 2009, 115: 1234. 10.1002/cncr.24149PubMedCrossRef du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J: Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d’Investigateurs Nationaux Pour les Etudes des Cancers de l’Ovaire (GINECO). Cancer 2009, 115: 1234. 10.1002/cncr.24149PubMedCrossRef
20.
go back to reference Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002, 20: 1248. 10.1200/JCO.20.5.1248PubMedCrossRef Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002, 20: 1248. 10.1200/JCO.20.5.1248PubMedCrossRef
21.
go back to reference Covens AL: A critique of surgical cytoreduction in advanced ovarian cancer. Gynecol Oncol 2000, 78: 269. 10.1006/gyno.2000.5926PubMedCrossRef Covens AL: A critique of surgical cytoreduction in advanced ovarian cancer. Gynecol Oncol 2000, 78: 269. 10.1006/gyno.2000.5926PubMedCrossRef
22.
go back to reference du Bois A, Rochon J, Pfisterer J, Hoskins WJ: Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review. Gynecol Oncol 2009, 112: 422. 10.1016/j.ygyno.2008.09.036PubMedCrossRef du Bois A, Rochon J, Pfisterer J, Hoskins WJ: Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: a systematic review. Gynecol Oncol 2009, 112: 422. 10.1016/j.ygyno.2008.09.036PubMedCrossRef
23.
go back to reference Wright JD, Lewin SN, Deutsch I: Defining the limits of radical cytoreductive surgery for ovarian cancer. Gynecol Oncol 2011, 123: 467. 10.1016/j.ygyno.2011.08.027PubMedCrossRef Wright JD, Lewin SN, Deutsch I: Defining the limits of radical cytoreductive surgery for ovarian cancer. Gynecol Oncol 2011, 123: 467. 10.1016/j.ygyno.2011.08.027PubMedCrossRef
24.
go back to reference Grilli R, Alexanian A, Apolone G: The impact of cancer treatment guidelines on actual practice in Italian general hospitals: the case of ovarian cancer. Ann Oncol 1990, 1: 112.PubMed Grilli R, Alexanian A, Apolone G: The impact of cancer treatment guidelines on actual practice in Italian general hospitals: the case of ovarian cancer. Ann Oncol 1990, 1: 112.PubMed
Metadata
Title
Clinical governance network for clinical audit to improve quality in epithelial ovarian cancer management
Authors
Vincenzo Dario Mandato
Martino Abrate
Pierandrea De Iaco
Debora Pirillo
Gino Ciarlini
Maurizio Leoni
Giuseppe Comerci
Alessandro Ventura
Bruno Lenzi
Andrea Amadori
Federica Rosati
Ruby Martinello
Rossana De Palma
Chiara Ventura
Laura Maria Beatrice Belotti
Debora Formisano
Giovanni Battista La Sala
Gynecological Oncology Network of Emilia Romagna Region
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Ovarian Research / Issue 1/2013
Electronic ISSN: 1757-2215
DOI
https://doi.org/10.1186/1757-2215-6-19

Other articles of this Issue 1/2013

Journal of Ovarian Research 1/2013 Go to the issue